The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...

In the future, therapies that focus on gut health—whether through diet, medication, or nerve stimulation—could be used to ...

After at least eight auditions, "Jeopardy!" superfan Harvey Silikovitz learned he was chosen to compete on the show. What he ...

Researchers say structure reveals many new ways to change PINK1, essentially switching it on, which will be "life-changing" for people with Parkinson’s disease.

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

Meiragtx's AAV-GAD program for Parkinson's disease is phase 3 ready, with positive data from a randomized, sham-controlled ...

The joint venture with generative AI firm Hologen hands MeiraGTx $200 million up front as well as other financial perks — a ...

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments.

It affects your mood, your sleep, even your motivation to exercise. There's convincing evidence that it's the starting point for Parkinson's disease and could be responsible for long COVID's cognitive ...

In the study, which was published in The BMJ, researchers analyzed data from 195 countries and territories using the 2021 ...